Genome Therapeutics Corporation

Genome Therapeutics Corp. is a leader in the field of genomics-based drug targets discovery -- the identification andfunctional characterization of genes. The Company has over ten years of experience in positional cloning, having served as one of the primary researchers under genome programs sponsored by the United States government, and has developed numerous techniques and tools that are widely used in this field. GTC's commercial gene discovery strategy capitalizes on its pioneering work in genomics by applying its high-throughput sequencing technology and positional cloning, its experience and skills in pathogen functional genomics and its bioinformatics capabilities. The two areas of focus are: the discovery and characterization of (i) genes of pathogens that are responsible for many serious diseases and (ii) human disease genes. The Company believes that its genomic discoveries may lead to the development of novel therapeutics, vaccines and diagnostic products by it and its strategic partners. The Company has entered into several corporate collaborations in connection with its pathogen and human gene discovery programs.

Contact Details: 100 Beaver Street Waltham MA 02453 United States of America Tel: 781 398 2300 Fax: 781 893 8277 Email: WWW: www.genomecorp.com/

Loading...

Recent Publications by Genome Therapeutics Corporation:
Bacterial targets to antimicrobial leads and development candidates. The unabated spread of drug-resistant bacterial pathogens continues to...	5th February, 2005	Genome Therapeutics Corporation, Waltham, MA 02453, USA.	Curr Opin Drug Discov Devel. 2004 Mar;7(2):211-22.
Evolutionary conservation and selection of human disease gene orthologs in the rat and mouse genomes. BACKGROUND: Model organisms have contributed substantially to our...	13th October, 2004	Department of Bioinformatics, Genome Therapeutics Corporation, Waltham, MA	Genome Biol. 2004;5(7):R47. Epub 2004 Jun 28. DOI Direct Link
Identification of potential cell-surface proteins in Candida albicans and investigation of the role of a putative cell-surface glycosidase in adhesion and virulence. Cell-surface proteins are attractive targets for the development of novel...	14th July, 2004	Genome Therapeutics Corporation, Waltham, MA 02453, USA.	Yeast. 2004 Mar;21(4):285-302. DOI Direct Link
Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase. Bacterial enoyl-acyl carrier protein reductase (ENR) catalyzes an...	21st June, 2004	Genome Therapeutics Corporation, Waltham, Massachusetts 02453, USA.	Antimicrob Agents Chemother. 2004 May;48(5):1541-7.
Mapping complex traits using Random Forests. Random Forest is a prediction technique based on growing trees on...	30th April, 2004	Genome Therapeutics Corporation, Waltham, Massachusetts 02453, USA.	BMC Genet. 2003 Dec 31;4 Suppl 1:S64. DOI Direct Link
→View more Genome Therapeutics Corporation research publications.

BioNews Results for Genome Therapeutics Corporation:
Genome-based Personalized Medicine	Genome Technology:  Aug 21 2008 4:49AM Matching: genome therapeutics
Genome map: a 30,000 bargain	The Times:  Aug 20 2008 9:57PM Matching: genome therapeutics
Personalized medicine: genes vs ethnicity; Venter vs Watson	Livemint.com:  Aug 20 2008 9:05AM Matching: genome therapeutics
Focus on the Worldwide Diagnostics Market Research Bundle (Worldwide Market for In Vitro Diagnostic Tests 6th	TMC Net:  Aug 19 2008 5:53PM Matching: genome therapeutics
Focus on the Worldwide Diagnostics Market Research Bundle (Worldwide Market for In Vitro Diagnostic Tests 6th	Canadian Business Magazine:  Aug 19 2008 4:10PM Matching: genome therapeutics
Promote your company here: BioNewsCast - Press Release Distribution	→View more Genome Therapeutics Corporation news.

Genome Therapeutics Corporation Patents:
US Patent No.	Title
7285400	High bone mass gene of 11q13.3
6583275	Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics
6583266	Nucleic acid and amino acid sequences relating to mycobacterium tuberculosis and leprae for diagnostics and therapeutics
6562958	Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
6551795	Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
→View more Genome Therapeutics Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 186 times since April 2007, the link to the organisation's website has been followed 41 times

Recent Search Terms used to find this page: Genome Therapeutics Corporation | genome therapeutics corporation | Genome Therapeutics Corporation | Genome Therapeutics Corporation | genome therapeutics corporation | Genome Therapeutics Corporation | genome therapeutics beaver | genome therapeutics corporation | .

Search for more companies in Waltham

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Genome Therapeutics Corporation